13F Pro13F Pro

TFG Asset Management GP Ltd

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1515070
Institutional-grade research for retail investors

Sector Allocation

  • Technology60.8%$373.3M
  • Healthcare30.3%$185.9M
  • Energy5.5%$33.8M
  • Industrials2.4%$14.6M
  • Communication Services1.1%$6.7M

AUM History

13fpro.ai/research/fund/tfg-asset-management-gp-ltd-1515070

Largest positions — Q2 2026

Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.

13fpro.ai/research/fund/tfg-asset-management-gp-ltd-1515070

TFG Asset Management GP Ltd 13F holdings — Q2 2026

$635.1M portfolio (+23.3% QoQ) · 39 holdings · Q2 2026 13F · top 10 are 77% of the stock portfolio

Includes $20.7M of put/call options ($0 puts, $20.7M calls), which 13F rules report at the value of the underlying shares, not the premium at risk. Stocks alone: $614.3M. Weights use the stock portfolio.

All holdings — TFG Asset Management GP Ltd (Q2 2026)

39 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.

Company
RLAY$RLAYRelay Therapeutics, Inc.$10.7M+214%
ARWR$ARWRARROWHEAD PHARMACEUTICALS, INC.$10.6M+3%
PHVS$PHVSPharvaris N.V.$10.2M+33%
ALKS$ALKSAlkermes plc.$10.0M+19%
IMVT$IMVTImmunovant, Inc.$9.9M+17%
AXSM$AXSMCALLAxsome Therapeutics, Inc.$8.6M—
SLN$SLNSilence Therapeutics plcadr$8.4M+21%
DYN$DYNDyne Therapeutics, Inc.$7.9M+38%
IONS$IONSIONIS PHARMACEUTICALS INC$7.7M+133%
AGIO$AGIOAGIOS PHARMACEUTICALS, INC.$7.6M+25%
HRMY$HRMYHarmony Biosciences Holdings, Inc.$7.3M+68%
KRYS$KRYSKrystal Biotech, Inc.$7.3M—
ANNX$ANNXAnnexon, Inc.$7.1M-4%
CELC$CELCCelcuity Inc.$6.7MNew
WBD$WBDWarner Bros. Discovery, Inc.$6.7M-73%

What changed in Q2 2026

Against the previous quarter's 13F: 10 new, 16 added to, 5 trimmed, 7 sold out. Share-count changes; largest moves by dollar size first.

New positions (10)

  • ALKT$ALKTALKAMI TECHNOLOGY, INC.$10.9M

    first bought this quarter

  • CELC$CELCCelcuity Inc.$6.7M

    first bought this quarter

  • RARE$RARECALLUltragenyx Pharmaceutical Inc.$3.3M

    first bought this quarter

  • SLN$SLNCALLSilence Therapeutics plc$3.3M

    first bought this quarter

  • CUE$CUECue Biopharma, Inc.$3.0M

    first bought this quarter

  • ACRS$ACRSAclaris Therapeutics, Inc.$2.1M

    first bought this quarter

+4 more in the Excel export

Added to (16)

  • PATH$PATHUiPath, Inc.+23%

    now $336.4M · held 6+ qtrs, 5 adds in a row

  • RLAY$RLAYRelay Therapeutics, Inc.+214%

    now $10.7M · held 2 qtrs, 2 adds in a row

  • IONS$IONSIONIS PHARMACEUTICALS INC+133%

    now $7.7M · held 2 qtrs, 2 adds in a row

  • DFTX$DFTXDefinium Therapeutics, Inc.+43%

    now $13.5M · held 2 qtrs, 2 adds in a row

  • MBX$MBXMBX Biosciences, Inc.+40%

    now $11.2M · held 4 qtrs, 2 adds in a row

  • HRMY$HRMYHarmony Biosciences Holdings, Inc.+68%

    now $7.3M · held 3 qtrs, 3 adds in a row

+10 more in the Excel export

Trimmed (5)

  • WBD$WBDWarner Bros. Discovery, Inc.-73%

    now $6.7M · held 2 qtrs

  • NKTR$NKTRNEKTAR THERAPEUTICS-16%

    now $6.1M · held 3 qtrs

  • CLDX$CLDXCelldex Therapeutics, Inc.-7%

    now $10.8M · held 6+ qtrs

  • AMLX$AMLXAmylyx Pharmaceuticals, Inc.-6%

    now $5.4M · held 5 qtrs

  • ANNX$ANNXAnnexon, Inc.-4%

    now $7.1M · held 6+ qtrs, 4 trims in a row

Sold out (7)

  • PRAX$PRAXPraxis Precision Medicines, Inc.was $5.1M

    held 2 qtrs

  • SLNO$SLNOSOLENO THERAPEUTICS INCwas $3.4M

    held 1 qtr

  • AXSM$AXSMAxsome Therapeutics, Inc.was $3.4M

    held 6+ qtrs

  • MPLT$MPLTMapLight Therapeutics, Inc.was $2.3M

    held 2 qtrs

  • AARD$AARDAardvark Therapeutics, Inc.was $1.2M

    held 1 qtr

  • RARE$RAREUltragenyx Pharmaceutical Inc.was $827K

+1 more in the Excel export

Share

Holdings by quarter

Every 13F TFG Asset Management GP Ltd has filed, 37 earlier quarters. Pick one to see what it held then.

Email me the moment this fund files its next 13FPro

Is it too late to follow TFG Asset Management GP Ltd?

Q2 2026 13F filed with the SEC on Aug 13, 2026. Prices are closing prices as of Oct 26, 2026.

Average quality of TFG Asset Management GP Ltd's top 20 holdings: 62/100 (our AI quality score, weighted by position size; 11 of the 20 are scored)

Top 10 since filing

-11.1%

Value-weighted move of the 10 largest stock positions

Turnover

7%

Last quarter; 28% over the last 4

Top 10 weight

77%

Share of the stock portfolio in its 10 largest positions

Held 4+ quarters

84%

Share of portfolio value in positions held a year or more

Highest-quality names it owns(among its 100 largest positions)

The 8 highest-scoring companies in this portfolio are a Pro feature.

How these are measured
  • Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
  • Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
  • Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q1 2025 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
  • Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
  • Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.

Portfolio Overview

TFG Asset Management GP Ltd disclosed 39 positions worth $635.1M in its Form 13F-HR for Q2 2026 — $614.3M in common stock plus $20.7M of put/call option positions (reported at underlying notional value, not premium at risk), led by $PATH (UiPath, Inc.) at 54.8% of the equity portfolio, followed by $KGEI and $AUTL. During the quarter the fund opened 10 new positions and exited 7 — including a new stake in $ALKT and a full exit from $PRAX. The portfolio is most concentrated in Technology (60.8% of disclosed assets). All figures are sourced directly from TFG Asset Management GP Ltd’s Form 13F-HR filing with the SEC under CIK 1515070.

Funds like this

managers whose biggest positions overlap TFG Asset Management GP Ltd's
Deep Track Capital, LP$6.87B 13F book · 8 shared top holdingsDFTXCLDXALKSIMVTBAKER BROS. ADVISORS LP$19.96B 13F book · 9 shared top holdingsALKSCELCIMVTARWRTCG Crossover Management, LLC$4.16B 13F book · 9 shared top holdingsRLAYIMVTDYNAMLXCommodore Capital LP$1.68B 13F book · 6 shared top holdingsDFTXCLDXRLAYPHVSARMISTICE CAPITAL, LLC$8.17B 13F book · 5 shared top holdingsIMVTAGIODYNHRMYAvoro Capital Advisors LLC$11.14B 13F book · 4 shared top holdingsDFTXARWRKRYSCELC

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

Berkshire HathawayBridgewater AssociatesCitadel AdvisorsRenaissance TechnologiesTwo Sigma InvestmentsDE Shaw & CoMillennium ManagementAQR Capital ManagementPoint72 Asset ManagementTiger Global ManagementVanguard GroupBlackRock

to search all 8,700+ institutional filers.

AI-Powered Hedge Fund Analysis: TFG Asset Management GP Ltd

13F Pro is an AI hedge fund tracker and stock research platform. For TFG Asset Management GP Ltd (SEC CIK: 1515070), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in TFG Asset Management GP Ltd's portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.